| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.solara.co.in | |
| Financial Indicators | ||
|---|---|---|
| Market Cap | 5,908.65 Cr. | |
| Earnings per share (EPS) | 61.62 | Trailing Twelve Months Ending 2021-03 |
| Price-Earning Ratio (PE) | 26.69 | Trailing Twelve Months Ending 2021-03 |
| Industry PE | 34.39 | Trailing Twelve Months Ending 2021-03 |
| Book Value / Share | 442.12 | Trailing Twelve Months Ending 2021-03 |
| Price to Book Value | 3.72 | Calculated using Price: 1,644.50 |
| Dividend Yield | 0.18 | Period Ending 2020-03 |
| No. of Shares Subscribed | 3.59 Cr. | 35,929,767 Shares |
| FaceValue | 10 | |
| Company Profile | ||
|
Solara Active Pharma Sciences is a dynamic, entrepreneurial and customer-oriented API manufacturer. It has a legacy of over three decades and trace its origins to the API expertise of Strides Shasun Ltd. and the technical know-how of human API business from Sequent Scientific Ltd. The company is poised to bridge the industry gap by delivering value-based products while maintaining focus on customer needs. It has hundreds of scientists working at its two R&D Centers and many API manufacturing facilities armed with global approvals and 2 dedicated R&D facilities. The company has a highly compliant manufacturing footprint spread over six large scale multi-product facilities. The company’s business is spread across several countries with extensive operations in the key markets of North America, Europe, Japan, South Korea and the Middle East and North Africa. Business area of the company The company is a global, R&D focused, pureplay API company engaged in the manufacturing and development of APIs and offering Contract Manufacturing and Development Services for global companies. Products and services
|
||
Company Profile
| 1 Day |
|
+1.05% |
| 1 Week |
|
-3.73% |
| 1 Month |
|
-2.45% |
| 3 Month |
|
+7.96% |
| 6 Month |
|
+10.70% |
| 1 Year |
|
+150.61% |
| 2 Year |
|
+398.56% |
| 5 Year |
|
| 3 years | 2018-03 | 2019-03 | 2020-03 | |
| Return on Equity (%) | 0.04 | 7.36 | 12.48 | |
| Return on Capital Employed (%) | 1.82 | 9.70 | 11.73 | |
| Return on Assets (%) | 0.02 | 3.14 | 5.57 |
| Particulars | 3 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Shh. Funds | 764 | 956 | 1,086 | |
| Non Curr. Liab. | 315 | 344 | 333 | |
| Curr. Liab. | 738 | 656 | 730 | |
| Minority Int. | 4 | 4 | 4 | |
| Equity & Liab. | 1,821 | 1,960 | 2,153 | |
| Non Curr. Assets | 1,214 | 1,312 | 1,481 | |
| Curr. Assets | 608 | 648 | 672 | |
| Misc. Exp. not W/O | ||||
| Total Assets | 1,821 | 1,960 | 2,153 |
| Particulars | 3 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Net Sales | 560 | 1,409 | 1,322 | |
| Other Income | 2 | 12 | 28 | |
| Total Income | 563 | 1,421 | 1,349 | |
| Total Expenditure | -501 | -1,197 | -1,062 | |
| PBIDT | 62 | 224 | 287 | |
| Interest | -25 | -82 | -78 | |
| Depreciation | -37 | -84 | -94 | |
| Taxation | 0 | 2 | 0 | |
| Exceptional Items | ||||
| PAT | 0 | 59 | 115 |
| Particulars | 3 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Cash Fr. Operatn. | 49 | 166 | 244 | |
| Cash Fr. Inv. | -85 | -116 | -359 | |
| Cash Fr. Finan. | 68 | -23 | 95 | |
| Net Change | 31 | 27 | -20 | |
| Cash & Cash Eqvt | 46 | 76 | 56 |
|
Fri, 30 Jul 2021
Reg. 34 (1) Annual Report Pursuant to Regulation 34 of SEBI (LODR) Regulations 2015 we enclose the Notice convening the 4th Annual General Meeting (AGM) of shareholders and Annual Report for the financial year 2020-21 which will be circulated to the shareholders through electronic mode for the AGM to be held on Wednesday August 25 2021 at 10.30 AM (IST) through video conference (VC). The Notice and the annual report will also be made available on the Companys website at www.solara.co.in |
|
Thu, 29 Jul 2021
Fixes Book Closure for Dividend & AGM Solara Active Pharma Sciences Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from Àugust 21 2021 to August 25 2021 (both days inclusive) for the purpose of Payment of Dividend & 4th Annual General Meeting (AGM) of the Company to be held on August 25 2021. |
|
Thu, 29 Jul 2021
Announcement under Regulation 30 (LODR)-Newspaper Publication Please find enclosed copies of the newspaper advertisement titled Annual General Meeting to be held over Video Conference Record Date and Final Dividend Information. The advertisements appeared in Business Standard and Lokmat (Marathi version). |
| Thu, 29 Jul 2021 |
Decreasing Relative Strength - Benchmark index
|
Decreasing Relative Strength - Sectoral index
|
Close Within 2 Year High Zone
|
Both SRS And ARS Above Zero
|
Close Crossing Current Month Low
|
Equities
M.F.
Sectors